Compare EHAB & ZJYL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EHAB | ZJYL |
|---|---|---|
| Founded | 2014 | 2006 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Hospital/Nursing Management | Industrial Specialties |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 692.9M | 292.7M |
| IPO Year | 2020 | 2020 |
| Metric | EHAB | ZJYL |
|---|---|---|
| Price | $14.00 | $1.98 |
| Analyst Decision | Hold | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $13.84 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 200.0K |
| Earning Date | 05-06-2026 | 08-20-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 97.11 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,060,000,000.00 | N/A |
| Revenue This Year | $6.42 | N/A |
| Revenue Next Year | $4.88 | N/A |
| P/E Ratio | ★ N/A | $18.40 |
| Revenue Growth | ★ 2.44 | N/A |
| 52 Week Low | $6.47 | $0.10 |
| 52 Week High | $14.22 | $2.86 |
| Indicator | EHAB | ZJYL |
|---|---|---|
| Relative Strength Index (RSI) | 76.25 | 70.71 |
| Support Level | $10.79 | $0.57 |
| Resistance Level | N/A | $2.86 |
| Average True Range (ATR) | 0.08 | 0.20 |
| MACD | -0.05 | -0.03 |
| Stochastic Oscillator | 63.71 | 49.09 |
Enhabit Inc provides home health and hospice services in the United States. Its reportable segments are Home Health and Hospice. The Home Health segment includes a comprehensive range of Medicare-certified home nursing services for adult patients in need of care. These services include, among others, skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. The Hospice segment focuses on the quality of life for patients who are experiencing a life-limiting illness while treating the person and symptoms of the disease, rather than the disease itself. The company generates a majority of its revenue from the Home Health segment.
Jin Medical International Ltd, along with its subsidiaries, mainly offers rehabilitation equipment. It is engaged in the design, development, manufacturing, and sales of wheelchairs and other assistive living aid products for use by people with disabilities or impaired mobility. The group's product offering includes wheelchairs and wheelchair components, oxygen concentrators, bathing machines, respiratory and walking aids, oxygen chambers, beauty instruments, and nano products, among others. Wheelchairs are currently its key revenue-generating product. The products are sold to dealers in Japan and China, and to some extent to dealers located in the United States, Canada, Australia, Korea, Israel, Singapore, and other regions. Geographically, the group generates maximum revenue from Japan.